ArticleHaematologica2023

Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients.

Justin C Laracy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.